Your browser doesn't support javascript.
loading
In vitro effects of emicizumab on activated clotting time in blood samples from cardiac surgical patients.
Tanaka, Kenichi A; Henderson, Reney; Thangaraju, Kiruphagaran; Morita, Yoshihisa; Mazzeffi, Michael A; Strauss, Erik; Katneni, Upendra; Buehler, Paul W.
Afiliação
  • Tanaka KA; Department of Anesthesiology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, USA.
  • Henderson R; Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Thangaraju K; Departments of Pathology and Pediatrics, Center for Blood Oxygen Transport, University of Maryland, Baltimore, Maryland, USA.
  • Morita Y; Department of Anesthesiology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, USA.
  • Mazzeffi MA; Department of Anesthesiology & Critical Care Medicine, George Washington University School of Medicine, Washington, District of Columbia, USA.
  • Strauss E; Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Katneni U; Departments of Pathology and Pediatrics, Center for Blood Oxygen Transport, University of Maryland, Baltimore, Maryland, USA.
  • Buehler PW; Departments of Pathology and Pediatrics, Center for Blood Oxygen Transport, University of Maryland, Baltimore, Maryland, USA.
Haemophilia ; 28(1): 183-190, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34735039
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Hemofilia A Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Hemofilia A Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article